Physician
General Surgery
Dr. David Z. Chu, OD
|
|
Give Review
David is an expert in the field of General Surgery. He went to David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical college. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. He has 2 awards "Top Doctors:LA Area" and "Fellow (FACS)". Doctor David Z. Chu, OD is a published physician. He published 57 publications, including: 'Resection with external beam and intraoperative radiotherapy for recurrent colon cancer.' David accepts all Medicare patients.
Publications
- Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer: a United States population-based assessment.
- A phase I trial of (90)Y-DOTA-anti-CEA chimeric T84.66 (cT84.66) radioimmunotherapy in patients with metastatic CEA-producing malignancies.
- Clear cell sarcoma in the era of sentinel lymph node mapping.
- Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
- A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer.
- Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis.
- Necrotizing gas-forming infections in cancer patients.
- Aromatic amine acetyltransferase as a marker for colorectal cancer: environmental and demographic associations.
- Immunosuppression in patients with metastatic squamous cell carcinoma from the skin.
- Purpura fulminans.
- Role of aromatic amine acetyltransferase in human colorectal cancer.
- Regional chemotherapy of liver metastases from colorectal carcinoma: hepatic artery or portal vein infusion?
- Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors.
- When is polypectomy sufficient treatment for colorectal cancer in a polyp?
- Prognostic significance of carcinoembryonic antigen in colorectal carcinoma. Serum levels before and after resection and before recurrence.
- Proton NMR of human breast tumors: correlation with clinical prognostic parameters.
- Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients.
- A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignanc...
- Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
- Surgical palliation at a cancer center: incidence and outcomes.
- CEA for monitoring colon cancer.
- The significance of synchronous carcinoma and polyps in the colon and rectum.
- Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.
- Revision and psychometric testing of the City of Hope Quality of Life-Ostomy Questionnaire.
- Esthetic reconstruction after mastectomy for inflammatory breast cancer: is it worthwhile?
- Beyond palliative mastectomy in inflammatory breast cancer--a reassessment of margin status.
- Indications and use of palliative surgery-results of Society of Surgical Oncology survey.
- Survey of physicians' attitudes relative to the field of surgical oncology.
- Ethnic differences in the behavior of hepatocellular carcinoma.
- Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer.
- Resection with external beam and intraoperative radiotherapy for recurrent colon cancer.
- Local recurrence in breast cancer: implications for systemic disease.
- Phase I trial of intraperitoneal gemcitabine in the treatment of advanced malignancies primarily confined to the peritoneal cavity.
- Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacoki...
- Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer.
- The role of pelvic exenteration in the management of recurrent rectal cancer.
- Online exclusive: patient and surgeon decision making regarding surgery for advanced cancer.
- Concerns of family caregivers of patients with cancer facing palliative surgery for advanced malignancies.
- The surgical treatment of cancer: a comparison of resource utilization following procedures performed with a curative and palliative intent.
- Adenoma recurrences after resection of colorectal carcinoma: results from the Southwest Oncology Group 9041 calcium chemoprevention pilot study.
- A prospective evaluation of palliative outcomes for surgery of advanced malignancies.
- Quality of life in patients with colorectal metastasis and intrahepatic chemotherapy.
- Impact of intraoperative radiation on postoperative and disease-specific outcome after pancreatoduodenectomy for adenocarcinoma: a propensity score analysis.
- Decision making in palliative surgery.
- Intraoperative radiation therapy for patients with recurrent rectal and sigmoid colon cancer in previously irradiated fields.
- Long-term survival after radical operations for cancer treatment-induced sarcomas: how two survivors invite reflection on oncologic treatment concepts.
- Current surgical options in the control of cancer pain.
- Evaluation of quality of life (QOL) in pancreaticoduodenectomy survivors.
- Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
- Cancer recurrence and survival associated with dietary patterns in stage III colon cancer.
- The surgeon's role in cancer prevention. The model in colorectal carcinoma.
- Clinicopathologic significance of synchronous and metachronous adenomas in colorectal cancer.
- Unaccounted breast cancers do not infer regression of tumors.
- Quality of care review: some progress, and toward what goal?
- Future of surgery: accountable care organizations and the end of private practice?
- Colorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions.
Doctors Specialties
- Optometry
- General Surgery
Accepted Insurances
Awards
- Top Doctors:LA Area
- Fellow (FACS)
Education
-
University of Texas MD Anderson Cancer Center -
University of California Davis -
University of California San Diego -
David Geffen School of Medicine at UCLA
Hospital
-
Santa Clara Valley Medical Center -
Huntington Memorial Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. David T. Fang, MD |
|
|
Dr. Tin T. Htwe, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Z. Chu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Garry D. Chan, OD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lily Mac, OD |
|
|
Dr. Jennifer T. Szeto, OD |
|
|
Dr. Phoenix Vuong, MD |